Procarta Biosystems

company

About

Procarta Biosystems develops antibacterials through an adaptable DNA-based platform to counter the rise of drug-resistant bacterial strains.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£730K
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

Procarta Biosystems Ltd., established in 2007 by the scientific founders, Dr. Michael McArthur and Professor Mervyn Bibb, is a spin-out company from the John Innes Centre, Norwich, a world renowned scientific centre of excellence in plant science and microbiology.
The company was initially established through Plant Bioscience Ltd (PBL), the internationally regarded group specialising in early stage technology investment and IP management, on behalf of the JIC, the Sainsbury Laboratory and the Biotechnology and Biological Sciences Research Council.

Procarta received seed funding in 2008 from the Rainbow and Iceni Seedcorn Funds and is currently headquartered on the Norwich Research Park.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
£1.05M $631K
Procarta Biosystems has raised a total of £1.05M $631K in funding over 2 rounds. Their latest funding was raised on Nov 10, 2010 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 10, 2010 Series Unknown £730K 1 Detail
Jun 6, 2008 Series Unknown $631K 1 Detail
Jul 1, 2007 Series Unknown £320K 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Procarta Biosystems is funded by 2 investors. Iceni Seedcorn Fund and NW Brown Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Iceni Seedcorn Fund Series Unknown
NW Brown Ventures Series Unknown